LDL cholesterol (mmol/L), change from baseline · adults without cardiovascular disease
1 finding from 1 review
HDL cholesterol (mmol/L), change from baseline · adults without cardiovascular disease
1 finding from 1 review
Triglycerides (mmol/L), change from baseline · adults without cardiovascular disease
1 finding from 1 review
Systolic blood pressure (mmHg), change from baseline · adults without cardiovascular disease
1 finding from 1 review
Diastolic blood pressure (mmHg), change from baseline · adults without cardiovascular disease
1 finding from 1 review
Adverse events · adults without cardiovascular disease
1 finding from 1 review
Total cardiac endpoints (all‐cause and cardiac deaths, myocardial infarction, hospital admissions for heart failure, unstable angina or stroke, unadjusted) · adults with established cardiovascular disease
It is very uncertain whether mediterranean dietary intervention changes total cardiac endpoints (all‐cause and cardiac deaths, myocardial… compared with another dietary intervention (very low certainty).
1 finding from 1 review
Total cholesterol (mmol/L), change from baseline · adults with established cardiovascular disease
1 finding from 1 review
LDL cholesterol (mmol/L), change from baseline · adults with established cardiovascular disease
1 finding from 1 review
HDL cholesterol (mmol/L), change from baseline · adults with established cardiovascular disease
1 finding from 1 review
Triglycerides (mmol/L), change from baseline · adults with established cardiovascular disease
1 finding from 1 review
Systolic blood pressure (mmHg), change from baseline · adults with established cardiovascular disease
1 finding from 1 review
Diastolic blood pressure (mmHg), change from baseline · adults with established cardiovascular disease
1 finding from 1 review
Adverse events · adults with established cardiovascular disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in weight (kg) · overweight and obese participants without T2DM (weight‐reducing phase only)
2 findings from 1 review
Weight loss of at least 5% at ≥ 12 months ‐ not measured · overweight and obese participants without T2DM (weight‐reducing phase followed by weight maintenance phase)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular mortality ‐ not measured · overweight and obese participants without T2DM (weight‐reducing phase followed by weight maintenance phase)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in DBP (mmHg) at ≥ 12 months · overweight and obese participants without T2DM (weight‐reducing phase followed by weight maintenance phase)
1 finding from 1 review
LDL cholesterol (mmol/L), change from baseline · overweight and obese participants without T2DM (weight‐reducing phase followed by weight maintenance phase)
1 finding from 1 review
Constipation at 3 to < 12 months ‐ not measured · overweight and obese participants without T2DM (weight‐reducing phase followed by weight maintenance phase)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found